Vanguard Group’s VIVEVE MED INC VIVE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-60,344
| Closed | -$25.6K | – | 4650 |
|
2022
Q4 | $25.6K | Sell |
60,344
-53,667
| -47% | -$22.8K | ﹤0.01% | 4485 |
|
2022
Q3 | $78K | Hold |
114,011
| – | – | ﹤0.01% | 4514 |
|
2022
Q2 | $75K | Hold |
114,011
| – | – | ﹤0.01% | 4564 |
|
2022
Q1 | $121K | Sell |
114,011
-27,095
| -19% | -$28.8K | ﹤0.01% | 4584 |
|
2021
Q4 | $161K | Buy |
141,106
+26,867
| +24% | +$30.7K | ﹤0.01% | 4580 |
|
2021
Q3 | $260K | Hold |
114,239
| – | – | ﹤0.01% | 4467 |
|
2021
Q2 | $338K | Buy |
114,239
+28,660
| +33% | +$84.8K | ﹤0.01% | 4320 |
|
2021
Q1 | $262K | Buy |
85,579
+70,000
| +449% | +$214K | ﹤0.01% | 4228 |
|
2020
Q4 | $73K | Buy |
+15,579
| New | +$73K | ﹤0.01% | 4167 |
|
2019
Q3 | – | Sell |
-1,369
| Closed | -$520K | – | 4170 |
|
2019
Q2 | $520K | Sell |
1,369
-461
| -25% | -$175K | ﹤0.01% | 3820 |
|
2019
Q1 | $1.72M | Buy |
1,830
+147
| +9% | +$138K | ﹤0.01% | 3500 |
|
2018
Q4 | $1.77M | Buy |
1,683
+702
| +72% | +$737K | ﹤0.01% | 3414 |
|
2018
Q3 | $2.63M | Buy |
981
+7
| +0.7% | +$18.8K | ﹤0.01% | 3441 |
|
2018
Q2 | $2.65M | Sell |
974
-19
| -2% | -$51.7K | ﹤0.01% | 3414 |
|
2018
Q1 | $3.63M | Buy |
993
+468
| +89% | +$1.71M | ﹤0.01% | 3266 |
|
2017
Q4 | $2.61M | Buy |
525
+62
| +13% | +$308K | ﹤0.01% | 3344 |
|
2017
Q3 | $2.42M | Buy |
463
+13
| +3% | +$68K | ﹤0.01% | 3347 |
|
2017
Q2 | $3.23M | Buy |
450
+259
| +136% | +$1.86M | ﹤0.01% | 3240 |
|
2017
Q1 | $1.21M | Buy |
191
+172
| +905% | +$1.09M | ﹤0.01% | 3530 |
|
2016
Q4 | $96K | Buy |
+19
| New | +$96K | ﹤0.01% | 3974 |
|